Skip to main content
. 2016 Oct;57:301–308. doi: 10.1016/j.fsi.2016.08.049

Table 1.

Comparison of phagocytic capacity between diploids and triploids in each treatment group.


Active macrophages consuming a given number yeast cells (%)
Treatment Ploidy 1 2 3 4 5 6 7 +
PBS Diploid 39.3a ± 2.6 24.7a ±2.8 16.8 ± 4.1 8.7 ± 1.5 4.9b ± 1.8 2.4b ± 1.2 1b ± 0.7 2.2b ± 1.2
Triploid 25.7b ± 4.7 19.2b ± 2.7 16.0 ± 2.7 12.9 ± 3.6 10.0a ± 2.0 5.4a ± 0.9 5.2a ± 1.6 5.6a ± 1.9
ADJ Diploid 33.5 ± 6.1 20.2 ± 1.4 18.0 ± 3.1 9.9 ± 2.8 9.0 ± 1.6 3.1 ± 1.0 3.4 ± 1.2 3.0 ± 2.0
Triploid 35.7 ± 7.2 19.0 ± 5.9 13.6 ± 4.6 8.9 ± 1.3 6.8 ± 2.4 5.5 ± 2.2 5.0 ± 2.3 4.5 ± 2.3
VACC Diploid 31.2 ± 7.7 15.8 ± 1.5 14.4 ± 3.0 10.2a ± 1.3 8.9 ± 3.1 5.6a ± 1.8 5.8a ± 1.7 8.1 ± 3.5
Triploid 46.0 ± 9.3 17.3 ± 5.7 10.6 ± 3.6 5.7b ± 2.6 5.4 ± 1.8 2.3b ± 1.6 2b ± 1.6 10.8 ± 5.3

Significant differences between ploidy are indicated by different lowercase superscripts.